PINC Research is bullish on CESC and has recommended buy rating on the stock with a target of Rs 350 in its May 9, 2012 research report.
PINC Research is bullish on NIIT Technologies and has recommended buy rating on the stock with a target of Rs 330 in its May 7, 2012 research report.
PINC Research is bullish on Infosys and has recommended accumulate rating on the stock with a target of Rs 2875 in its April 13, 2012 research report.
PINC Research has come out with its report on automobile monthly sales. The research firm believes demand for petrol vehicles would remain subdued in FY13 too and growth would be largely driven by the diesel variants.
PINC Research is bullish on KPIT Cummins and has recommended buy rating on the stock with a target of Rs 103 in its March 21, 2012 research report.
PINC Research has come out with its report on Mumbai realty. According to the research firm has preferred DLF (upside - 48%) and HDIL(107%) in the large cap space and Phoenix (24%) and Puravankara (120%) in mid caps.
PINC Research is bullish on Bata India and has recommended buy rating on the stock with a target of Rs 805 in its March 20, 2012 research report.
PINC Research has come out with its report on auto sector. According to the research firm the large eastern states namely Bihar, West Bengal, Odisha and Andhra Pradesh could be the drivers of growth over 2011-21 as prosperity percolates to these regions.
PINC Research has come out with its high-conviction stock ideas for March 2012. Ashoka Buildcon, HSIL, India Cements, Infosys, Jagran Prakashan, Jyothy Laboratories, Mahindra & Mahindra, MRPL, Nestle India, NIIT Tech, Phoenix Mills, Power Grid Corporation, Tecpro Systems are the stocks from across sectors.
PINC Research is bullish on Century Textiles and has recommended buy rating on the stock with a target of Rs 375 -380 in its March 13, 2012 research report.
PINC Research has come out with its report on pharma sector. According to the research firm Cipla has applied for voluntary licenses for Raltegravir (ARV drug) to Merck while Natco has also applied for Maraviroc (ARV drug) to Pfizer/Glaxo.
PINC Research is bullish on CESC and has recommended buy rating on the stock with a target of Rs 350 in its March 9, 2012 research report.
PINC Research has come out with its report on IT sector. The research firm has prefered Infosys, TCS and HCL Tech from large caps and NIIT Tech, MindTree and Hexaware from mid-caps.
PINC Research has come out with its report on media & entertainment conference note. "We reiterate that regional players will be better placed during the current economic slowdown. Despite slowdown in national advertising, local spending (Automobile, FMCG, Clothing) will provide support to the regional players."
PINC Research is bullish on Phoenix Mills and has recommended buy rating on the stock with a target of Rs 265 in its March 5, 2012 research report.
PINC Research has come out with its report on NHAI. "With only one month left to meet its targets of 7300km, NHAI is putting its act together to award the remaining ~3015km of road projects. Considering the awarded projects, current bid stage and execution; we believe NHAI will miss both its target of awarding and completion."
PINC Research has recommended reduce rating on MphasiS with a target price of Rs 400 in its March 2, 2012 research report.
PINC Research is bearish on GlaxoSmithKline Pharma and has recommended sell rating on the stock with a target of Rs 1880 in its March 1, 2012 research report.
PINC Research is bullish on Bata India and has recommended buy rating on the stock with a target of Rs 805 in its February 29, 2012 research report.
PINC Research is bullish on Cadila Healthcare and has recommended accumulate rating on the stock with a target of Rs 751 in its February 29, 2012 research report.
PINC Research is bullish on Gujarat Gas Company and has recommended buy rating on the stock with a target of Rs 478 in its February 23, 2012 research report.
PINC Research is bearish on Ranbaxy Labs and has recommended sell rating on the stock with a target of Rs 337 in its February 23, 2012 research report.
PINC Research is bearish on GlaxoSmithKline Pharmaceuticals (GSK Pharma) and has recommended sell rating on the stock with a target price of Rs 1880 in its February 16, 2012 research report.
PINC Research is bearish on Sun Pharma and has recommended reduce rating on the stock with a target of Rs 534 in its February 16, 2012 research report.
PINC Research is bearish on Marico and has recommended reduce rating on the stock with a target of Rs 150 in its February 15, 2012 research report.